Citations

Mayo Clinic

Showing 10 of 108551 citations.

Surgical Management and Reconstruction of Hoffman’s Disease (Dissecting Cellulitis of the Scalp)
Hintze, Justin M. , Howard, Brittany E. , Donald, Carrlene B., Hayden, Richard E. , Hintze, Justin

Case Reports in Surgery | February 7, 2016 | Volume: 2016 | Issue: No issue available | Pages: 1-4

10.1155/2016/2123037 | PMID 26966606 Get It

Dissecting cellulitis of the scalp, or Hoffman’s disease, is a rare dermatologic condition characterized by recurrent pustules and sinus tract formation leading to scarring and alopecia. Medical management includes the use of corticosteroids, antibiotics, isotretinoin, and adalimumab. In cases where the disease is severe, refractory, and intractable, surgery is an option. We report two cases of Hoffman’s disease, where medical management failed to achieve remission. Surgical treatment was undertaken with complete resection of the affected scalp in staged procedures with subsequent split-thickness skin grafting for reconstruction. Surgery achieved both disease remission and excellent aesthetic outcomes in both patients.
Harnessing next-generation informatics for personalizing medicine: a report from AMIA’s 2014 Health Policy Invitational Meeting
Wiley, Laura K. , Tarczy‐Hornoch, Peter , Denny, Joshua C. , Freimuth, Robert R. , Overby, Casey Lynnette, Martin, Ross D., Taylor, Casey Overby , Shah, Nigam H. , Sarkar, Indra Neil , Denny, Joshua C , Freimuth, Robert R , Wiley, Laura K

Journal of the American Medical Informatics Association | February 6, 2016 | Volume: 23 | Issue: 2 | Pages: 413-419

10.1093/jamia/ocv111 | PMID 26911808 Get It

Abstract The American Medical Informatics Association convened the 2014 Health Policy Invitational Meeting to develop recommendations for updates to current policies and to establish an informatics research agenda for personalizing medicine. In particular, the meeting focused on discussing informatics challenges related to personalizing care through the integration of genomic or other high-volume biomolecular data with data from clinical systems to make health care more efficient and effective. This report summarizes the findings ( n = 6) and recommendations ( n = 15) from the policy meeting, which were clustered into 3 broad areas: (1) policies governing data access for research and personalization of care; (2) policy and research needs for evolving data interpretation and knowledge representation; and (3) policy and research needs to ensure data integrity and preservation. The meeting outcome underscored the need to address a number of important policy and technical considerations in order to realize the potential of personalized or precision medicine in actual clinical contexts.
Stress-coping skills and neuroticism in apical ballooning syndrome (Takotsubo/stress cardiomyopathy)
Rohe, Daniel E. , Best, Patricia J.M. , Lennon, Ryan J. , Scantlebury, Dawn C. , Lennon, Ryan J. , Lerman, Amir , Prasad, Abhiram

Open Heart | February 5, 2016 | Volume: 3 | Issue: 1 | Pages: e000312

10.1136/openhrt-2015-000312 | PMID 26870388 Get It

Introduction Apical ballooning syndrome (ABS) is typically associated with an antecedent stressful situation. Affected patients have been reported to have higher frequencies of premorbid affective disorders. We hypothesised that patients with ABS would have elevated levels of neuroticism (tendency to experience negative affect) and greater vulnerability to stress. Methods In this cross-sectional study, all active participants in the Mayo Clinic ABS prospective follow-up registry were invited to complete the third edition of the NEO Personality Inventory (NEO-PI-3). The NEO-PI-3 is the universally accepted measure of the ‘Five-Factor Model’ of personality. Inventory responses were scored using the NEO-PI-3 computer program and the data were compared with US normative sample used in standardisation of the inventory. Significance was set at 0.0014 to account for multiple comparisons. Results Of 106 registry participants approached, 53 completed the inventory. There was no difference in age, gender, time from ABS diagnosis, type of antecedent stressor (emotional, physical or none) or severity of initial illness between the responders and non-responders. Responders had mean Neuroticism T-scores of 48.0±10.6 (95% CI 45.1 to 50.9); p=0.18, when compared with the normal mean of 50. There was also no significant difference in the facet scale of Vulnerability: 46.9±8.4 (44.6 to 49.2), p=0.038, at α=0.0014. Conclusions Contrary to our hypothesis, patients with ABS do not manifest higher levels of neuroticism and do not have greater vulnerability to stress than the general population. These findings have implications for the clinicians’ perception of, and approach to, patients with ABS.
Biologic and clinical characteristics of adolescent and young adult cancers: Acute lymphoblastic leukemia, colorectal cancer, breast cancer, melanoma, and sarcoma
Tricoli, James V. , Blair, Donald G., Anders, Carey K. , Bleyer, W. Archie, Boardman, Lisa A., Khan, Javed , Hayes‐Lattin, Brandon , Merchant, Melinda S., Seibel, Nita L. , Thurin, Magdalena , Boardman, Lisa A., Kummar, Shivaani , Hunger, Stephen P. , Willman, Cheryl L.

Cancer | February 5, 2016 | Volume: 122 | Issue: 7 | Pages: 1017-1028

10.1002/cncr.29871 | PMID 26849082 Get It

Adolescent and young adult (AYA) patients with cancer have not attained the same improvements in overall survival as either younger children or older adults. One possible reason for this disparity may be that the AYA cancers exhibit unique biologic characteristics, resulting in differences in clinical and treatment resistance behaviors. This report from the biologic component of the jointly sponsored National Cancer Institute and LiveStrong Foundation workshop entitled “Next Steps in Adolescent and Young Adult Oncology” summarizes the current status of biologic and translational research progress for 5 AYA cancers; colorectal cancer breast cancer, acute lymphoblastic leukemia, melanoma, and sarcoma. Conclusions from this meeting included the need for basic biologic, genomic, and model development for AYA cancers as well as translational research studies to elucidate any fundamental differences between pediatric, AYA, and adult cancers. The biologic questions for future research are whether there are mutational or signaling pathway differences (for example, between adult and AYA colorectal cancer) that can be clinically exploited to develop novel therapies for treating AYA cancers and to develop companion diagnostics. Cancer 2016;122:1017–1028. © 2016 American Cancer Society
Magnetic Resonance Imaging-Guided, Open-Label, High-Frequency Repetitive Transcranial Magnetic Stimulation for Adolescents with Major Depressive Disorder
Wall, Christopher A., Croarkin, Paul E. , Maroney‐Smith, Mandie, Haugen, Laura M., Baruth, Joshua , Frye, Mark A. , Sampson, Shirlene , Port, John D. , Maroney-Smith, Mandie J, Sampson, Shirlene M, Croarkin, Paul E , Port, John D

Journal of Child and Adolescent Psychopharmacology | February 5, 2016 | Volume: 26 | Issue: 7 | Pages: 582-589

10.1089/cap.2015.0217 | PMID 26849202 Get It

Objective: Preliminary studies suggest that repetitive transcranial magnetic stimulation (rTMS) may be an effective and tolerable intervention for adolescents with treatment-resistant depression. There is limited rationale to inform coil placement for rTMS dosing in this population. We sought to examine and compare three localization techniques for coil placement in the context of an open-label trial of high-frequency rTMS for adolescents with treatment-resistant depression. Methods: Ten adolescents with treatment-resistant depression were enrolled in an open-label trial of high-frequency rTMS. Participants were offered 30 rTMS sessions (10 Hz, 120% motor threshold, left 3000 pulses applied to the dorsolateral prefrontal cortex) over 6–8 weeks. Coil placement for treatment was MRI guided. The scalp location for treatment was compared with the locations identified with standard 5 cm rule and Beam F3 methods. Results: Seven adolescents completed 30 rTMS sessions. No safety or tolerability concerns were identified. Depression severity as assessed with the Children's Depression Rating Scale Revised improved from baseline to treatment 10, treatment 20, and treatment 30. Gains in depressive symptom improvement were maintained at 6 month follow-up visits. An MRI-guided approach for coil localization was feasible and efficient. Our results suggest that the 5 cm rule, Beam F3, and the MRI-guided localization approaches provided variable scalp targets for rTMS treatment. Conclusions: Open-label, high-frequency rTMS was feasible, tolerable, and effective for adolescents with treatment-resistant depression. Larger, blinded, sham-controlled trials are needed for definitive safety and efficacy data. Further efforts to understand optimal delivery, dosing, and biomarker development for rTMS treatments of adolescent depression are warranted.
The Dohner fluorescence in situ hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience
Dyke, Daniel L. Van , Werner, Lillian , Rassenti, Laura Z., Ghia, Emanuella, Heerema, Nyla A. , Cin, Paola Dal , Aquila, Marie Dell, Sreekantaiah, Chandrika, Greaves, Andrew, Van Dyke, Daniel L, Neuberg, Donna , Kipps, Thomas J. , Kay, Neil E.

British Journal of Haematology | February 5, 2016 | Volume: 173 | Issue: 1 | Pages: 105-113

10.1111/bjh.13933 | PMID 26848054 Get It

SummaryThis study revisited the Dohner prognostic hierarchy in a cohort of 1585 well‐documented patients with chronic lymphocytic leukaemia. The duration of both time to first treatment (TTFT) and overall survival (OS) were significantly longer than observed previously, and this is at least partly due to improved therapeutic options. Deletion 13q remains the most favourable prognostic group with median TTFT and OS from fluorescence in situ hybridization (FISH) testing of 72 months and >12 years, respectively. Deletion 11q had the poorest median TTFT (22 months) and 17p deletion the poorest median OS (5 years). The percentages of abnormal nuclei were significantly associated with differential TTFT for the trisomy 12, 13q and 17p deletion cohorts but not for the 11q deletion cohort. From the date of the first FISH study, patients with >85% 13q deletion nuclei had a notably shorter TTFT (24 months). Patients with ≤20% 17p deletion nuclei had longer median TTFT and OS from the date of the first FISH study (44 months and 11 years), and were more likely to be IGHV mutated.
The Method for Performance Measurement Matters: Diabetes Care Quality as Measured by Administrative Claims and Institutional Registry
Tulledge‐Scheitel, Sidna M. , Naessens, James M. , Glasgow, Amy E. , Stroebel, Robert J. , Crane, Sarah J. , Bunkers, Kari S., Shah, Nilay D. , Glasgow, Amy E. , Tulledge-Scheitel, Sidna M, McCoy, Rozalina G. , Glasgow, Amy E

Health Services Research | February 5, 2016 | Volume: 51 | Issue: 6 | Pages: 2206-2220

10.1111/1475-6773.12453 | PMID 26846443 Get It

ObjectivesPerformance measurement is used by health care providers, payers, and patients. Historically accomplished using administrative data, registries are used increasingly to track and improve care. We assess how measured diabetes care quality differs when calculated using claims versus registry.Data Sources/Study SettingCross‐sectional analysis of administrative claims and electronic health records (EHRs) of patients in a multispecialty integrated health system in 2012 (n = 368,883).Study DesignWe calculated percent of patients attaining glycohemoglobin <8.0 percent, LDL cholesterol <100 mg/dL, blood pressure <140/90 mmHg, and nonsmoking (D4) in cohorts, identified by Medicare Accountable Care Organization/Minnesota Community Measures (ACO‐MNCM; claims‐based), Healthcare Effectiveness Data and Information Set (HEDIS; claims‐based), and registry (EHR‐based).Data Collection/Extraction MethodsClaims were linked to EHR to create a dataset of performance‐eligible patients.Principal FindingsACO‐MNCM, HEDIS, and registry identified 6,475, 6,989, and 6,425 measurement‐eligible patients. Half were common among the methods; discrepancies were due to attribution, age restriction, and encounter requirements. D4 attainment was lower in ACO‐MNCM (36.09 percent) and HEDIS (37.51 percent) compared to registry (43.74 percent) cohorts.ConclusionsRegistry‐ and claims‐based performance measurement methods identify different patients, resulting in different rates of quality metric attainment with implications for innovative population health management.
Bilateral Foot Gangrene
Stopsack, Konrad H. , Vinod Shah, Mithun, Shah, Meera , Stopsack, Konrad H

JAMA Oncology | February 5, 2016 | Volume: 2 | Issue: 3 | Pages: 387

10.1001/jamaoncol.2015.6156 | PMID 26847423 Get It

Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study
Amirian, E. Susan , Zhou, Renke, Wrensch, Margaret , Olson, Sara H. , Scheurer, Michael E. , Armstrong, Georgina , McCoy, Lucie , Lau, Ching C., Claus, Elizabeth B. , Barnholtz‐Sloan, Jill S. , Schildkraut, Joellen M. , Ali‐Osman, Francis, Sadetzki, Siegal , Johansen, Christoffer , Houlston, Richard S. , Jenkins, Robert B. , Bernstein, Jonine L. , Merrell, Ryan , Davis, Faith G., Lai, Rose , Shete, Sanjay , Melin, Beatrice , Bondy, Melissa L. , Lachance, Daniel, Il’yasova, Dora , Lachance, Daniel Honore , Armstrong, Georgina , Amos, Christopher I. , Houlston, Richard S , Barnholtz-Sloan, Jill S

Cancer Epidemiology, Biomarkers & Prevention | February 5, 2016 | Volume: 25 | Issue: 2 | Pages: 282-290

10.1158/1055-9965.epi-15-0847 | PMID 26908595 Get It

Abstract Background: Several previous studies have found inverse associations between glioma susceptibility and a history of allergies or other atopic conditions. Some evidence indicates that respiratory allergies are likely to be particularly relevant with regard to glioma risk. Using data from the Glioma International Case-Control Study (GICC), we examined the effects of respiratory allergies and other atopic conditions on glioma risk. Methods: The GICC contains detailed information on history of atopic conditions for 4,533 cases and 4,171 controls, recruited from 14 study sites across five countries. Using two-stage random-effects restricted maximum likelihood modeling to calculate meta-analysis ORs, we examined the associations between glioma and allergy status, respiratory allergy status, asthma, and eczema. Results: Having a history of respiratory allergies was associated with an approximately 30% lower glioma risk, compared with not having respiratory allergies (mOR, 0.72; 95% confidence interval, 0.58–0.90). This association was similar when restricting to high-grade glioma cases. Asthma and eczema were also significantly protective against glioma. Conclusion: A substantial amount of data on the inverse association between atopic conditions and glioma has accumulated, and findings from the GICC study further strengthen the existing evidence that the relationship between atopy and glioma is unlikely to be coincidental. Impact: As the literature approaches a consensus on the impact of allergies in glioma risk, future research can begin to shift focus to what the underlying biologic mechanism behind this association may be, which could, in turn, yield new opportunities for immunotherapy or cancer prevention. Cancer Epidemiol Biomarkers Prev; 25(2); 282–90. ©2016 AACR.
Tools of the Trade: Point-of-Care Ultrasonography as a Stethoscope
Sekiguchi, Hiroshi

Seminars in Respiratory and Critical Care Medicine | February 4, 2016 | Volume: 37 | Issue: 01 | Pages: 068-087

10.1055/s-0035-1570353 | PMID 26844609 Get It